Asian Clinical Trials (ACT), the clinical research division of Suven Life Sciences, has entered into a strategic alliance with VPSCRO, a contract research organisation based in Beijing, to conduct clinical trial services in India and China.Venkat Jasti, CEO, Suven, said: "This strategic alliance between ACT and VPSCRO will allow us to offer a comprehensive range of clinical services to global sponsors with state-of-the-art infrastructure and a network of trained investigators in India and China."
